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Abstract
Objectives:  To  describe  the  trends  of  research  design  in  publications  from  high-impact  medical
journals.
Methods: A  cross-sectional,  descriptive  study  was  conducted  by  searching  the  2011  electronic
publications  of  the  journals:  New  England  Journal  of  Medicine,  Journal  of  the  American  Medical
Association,  The  Lancet,  British  Medical  Journal,  and  Annals  of  Internal  Medicine.  Studies  were
classiﬁed as  primary  and  secondary.  The  journal  impact  factor  was  taken  from  the  Journal
Citation Report  website.  Descriptive  statistics  were  used  to  analyze  and  interpret  the  data.
Results:  We  analyzed  1130  publications:  804  primary  and  326  secondary  studies,  which  rep-
resented  71.2%  and  28.8%  of  the  total  publications,  respectively.  Among  the  primary  studies,
randomized  clinical  trials  (30.4%)  were  the  most  prevalent,  followed  by  cohort  studies  (21.9%)
and case  reports  (9.0%).
Conclusions:  These  ﬁndings  can  have  implications  in  Evidence-Based  Medicine  programs.  Liter-
ature review  should  focus  on  reviewing  secondary  articles  ﬁrst,  then  experimental  studies  and
ﬁnally, observational  studies.
© 2015  Published  by  Masson  Doyma  México  S.A.  on  behalf  of  Universidad  Autónoma  de  Nuevo
León. This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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n  the  area  of  continuous  medical  education,  in  order  to
chieve  the  gold  standard  in  medical  attention,  growth  and
urrent  information,  frequent  review  of  medical  literature
s  necessary.  In  modern  medicine,  healthcare  excellence  is
ombined  with  scientiﬁc  rigor  in  the  practice  of  evidence-
ased  medicine  (EBM).  This  new  paradigm  in  medical
ducation  integrates  the  use  of  the  best  clinical  evidence
niversidad Autónoma de Nuevo León. This is an open access article
y-nc-nd/4.0/).
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sTendencies  in  medical  publications  
and  experience  in  the  diagnostic  and  therapeutic  decision-
making  process.  Proposed  in  1992,1 its  implementation
has  been  replacing  the  authoritarian  management  and  the
purely  heuristic  in  medicine.  Using  competences  such  as
search  strategies,  critical  reading  and  the  application  of  evi-
dence  to  the  context  of  the  patient2,3 to  create  and  base  an
intervention.  Some  of  its  objectives  are:  to  promote  criti-
cal  thinking,  to  promote  continuous  learning,  to  reduce  the
impact  of  medical  error  and  improve  the  patient’s  progno-
sis.  Nevertheless,  despite  having  acceptance  among  some
medical  circles;  critics  point  out  the  difﬁculty  of  integrating
EBM  into  clinical  practice.4--6 They  question  its  epistemo-
logical  value7,8 and  comment  regarding  the  resistance  of  its
implementation  in  some  health  centers  and  universities.9
Regarding  medical  education,  the  integration  of  a
dynamic  learning  model  must  deliver  results  and  content.  An
adequate  curriculum  should  categorize  content  according  to
its  level  of  complexity  and  difﬁculty.  In  the  evidence-based
medicine  scenario,  the  competences  must  prepare  doctors
to  evaluate  and  integrate  the  best  evidence  in  order  to  gen-
erate  an  answer  to  a  clinical  problem.  But,  taking  this  into
consideration,  what  does  it  take  to  answer  a  clinical  ques-
tion?  In  the  process  of  critical  reading,  a  study  can  apply
to  clinical  context  if  it  complies  with  internal  and  exter-
nal  validity.  Therefore,  the  search  of  studies  with  a  high
level  of  evidence  is  the  ﬁrst  step.  This  represents  a fact
in  medical  journals  with  a  high  impact  factor.  First,  in  the
review-by-pairs  process,  reviewers  included  in  the  editorial
committee  publish  in  high  impact  journals.10 Concerning  the
researcher’s  participation,  they  recruit  a  higher  number  of
patients,  evaluate  major  results  and  analyze  subgroups.11
With  the  selection  of  publications,  the  ‘‘method’’  section
is  evaluated  on  the  integrity  of  the  statistical  analysis,12
while  in  ‘‘results’’,  the  inclusion  of  a  conﬁdence  interval13
and  clinical  signiﬁcance  range  is  common.14 Despite  all  of
the  above,  research  design  may  offer  a  replicable  example
of  information  with  high  clinical  value.  Thus,  the  objective
of  the  present  study  is  to  examine  the  publication  tenden-
cies  in  the  different  research  designs  in  high-impact  medical
journals.
Materials and methods
A  transversal  descriptive  study  was  conducted.  We  eval-
uated  issues  of  the  following  journals  published  during
2011:  The  New  England  Journal  of  Medicine,  Journal
of  the  American  Medical  Association,  Annals  of  Internal
Medicine,  The  Lancet  and  BMJ.  The  impact  factor  was
obtained  from  the  Journals  Citation  Report.15 These  pub-
lications  were  then  classiﬁed  as  primary  (originals)  and
secondary  (revisions)  studies  according  to  their  focus.  The
main  studies  section  was  sub-divided  according  to  the
type  of  study  and  experimental  (randomized  clinical  tri-
als)  and  observational  designs  (prevalence,  control  case
and  cohort).  The  secondary  studies  section  included:  nar-
rative  review  and  systematic  review,  with  and  without
meta-analysis,  excluding  genomic  studies  of  this  cate-
gory.
Descriptive  statistics  were  utilized  for  better  data  mana-
gement  and  interpretation.
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ut  of  the  1130  publications  analyzed  in  2011,  the  jour-
als  published  an  average  of  3  main  studies  and  1  secondary
tudy  per  issue  (results  shown  in  Table  1).  337  randomized
linical  trials  (30.4%)  were  published  in  the  main  studies  cat-
gory.  On  the  other  hand,  observational  studies  243  (21.9%),
ncluded  102  cohorts  (9.02%),  59  case  reports  (5.2%)  and
2  (4.6).  Regarding  the  secondary  studies,  226  publications
ere  classiﬁed  as  narrative  reviews  (20%),  67  as  systemic
eviews  (5.9%)  and  33  as  systemic  reviews  with  meta-analysis
2.9%).
The  New  England  Journal  of  Medicine  published  241  arti-
les,  divided  as  follows:  0  (0%)  meta-analysis,  1  (0.5%)
ystematic  review,  33  (15.55%)  narrative  reviews,  110
51.4%)  clinical  essays,  17  (7.9%)  cohorts,  6  (2.8%)  control
ases,  5  (2.3%)  prevalence  and  42  (19.6%)  case  reports.
The  Lancet  published  337  articles,  divided  as  follows:
 (1.8%)  meta-analysis,  3  (0.9%)  systematic  reviews,  120
35.6%)  narrative  reviews,  110  (29.7%)  randomized  clinical
rials,  46  (13.6%)  cohorts,  4  (1.2%)  control  cases,  5  (1.2%)
revalence  and  53  (15.7%)  case  reports.
The  Journal  of  the  American  Medical  Association,  for  its
art,  published  202  studies,  divided  as  follows:  18  (8.9%)
eta-analysis,  2  (1%)  systematic  reviews,  14  (6.9%)  narrative
eviews,  42  (20.8%)  randomized  clinical  trials,  81  (40.1%)
ohorts,  32  (15.8%)  control  cases,  10  (5%)  prevalence  and  3
1.5%)  case  reports.
BMJ  included  270  publications,  divided  as  follows:  1
0.4%)  meta-analysis,  43  (15.9%)  systematic  reviews,  53
19.6%)  narrative  reviews,  72  (26.7%)  randomized  clinical
rials,  69  (25.6%)  cohorts,  15  (5.6%)  control  cases,  17  (6.3%)
revalence  and  0  (0%)  case  reports.
Last  but  not  least,  Annals  of  Internal  Medicine  published
07  studies,  divided  as  follows:  8  (7.5%)  meta-analysis,  18
16.8%)  systematic  reviews,  6 (5.6%)  narrative  reviews,  20
18.7%)  randomized  clinical  trials,  34  (31.8%)  cohorts,  2
1.9%)  control  cases,  15  (14%)  prevalence  and  4  (3.7%)  case
eports.
Regarding  original  studies,  NEJM  published  180  (84.1%),
he  Lancet  208  (61.7%),  JAMA  168  (83.2%),  BMJ  173  (64.1%)
nd  Annals  of  Internal  Medicine  75  (70.1%).  The  tendencies
or  secondary  studies  were  NEJM  34  (15.9%),  The  Lancet
29  (38.3%),  JAMA  34  (16.8%),  BMJ  97  (35.9%)  and  Annals
f  Internal  Medicine  32  (39.9%).
iscussion
n  our  frequency  distribution  analysis,  publication  distribu-
ion  was  linked  to  evidence  levels.  Randomized  clinical  trials
ere  the  most  represented  studies,  followed  by  cohorts.
ur  results  suggest  that  medical  journals  with  a  high-impact
actor  publish  studies  with  a  high  evidence  level  (Fig.  1).
A  relevant  ﬁnding  signiﬁcantly  documented  in  The  New
ngland  Journal  of  Medicine  and  The  Lancet  was  the  high
requency  with  which  case  reports  were  published,  repre-
enting  up  to  15%  of  the  total  of  their  publications.  Another
ajor  ﬁnding  is  the  tendencies  the  journals  have  according
o  their  geographic  location.  European  journals  (The  Lancet
nd  BMJ)  published  secondary  studies  to  a  greater  extent
Fig.  2).  These  ﬁndings  raise  a  question:  What  implications
140  H.E.  Tamez-Pérez  et  al.
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an  this  have?  In  order  to  answer  this  question  correctly,  the
imitations  and  advantages  of  each  design  were  evaluated.
Experimental  studies  represent  a  high  degree  of  evi-
ence  since  they  allow  a  direct  determination  of  the
ausal  connection  of  two  phenomena.  Another  signiﬁcant
oint  is  its  ability  to  reduce  the  amount  of  systematic
rrors.16 With  randomization,  an  equilibrium  between  the
haracteristics  of  the  compared  groups  is  established.
linding,  concealment  and  intention-to-treat  analysis  allow
he  reduction  of  skewing  in  any  type  of  randomized  clinical
rial.  Unfortunately,  one  of  the  biggest  disadvantages  of
CT  is  in  the  context  of  clinical  practice.  Paradoxically,
nternal  factors  such  as  the  strict  inclusion  criteria,  eval-
ation  of  efﬁciency  and  short-term  follow-up17 limit  the
tudy’s  ability  to  establish  a  general  conclusion.  The  fact
hat  signiﬁcant  results  are  obtained  does  not  necessarily
ean  that  they  can  be  applied  in  a  ‘‘real  life’’  scenario.  In
ther  words,  the  results  at  that  moment  only  apply  to  the
opulation  being  studied.  Also  external  factors  of  the  study
ike  high  costs,  ethical  considerations18 and  low  ﬁnancing
n  the  case  of  rare  diseases  are  also  an  important  issue.
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Figure  2  Distribution  of  original  and  secondary  studies.
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Consequently,  the  difﬁculty  in  clinical  trials  relies  more
importantly  on  external  validation.
Observational  studies  represent  the  lowest  level  in  the
evidence  hierarchy.  They  are  useful  in  clinical  scenarios  like
in  evaluating  disparity  and  load  and  determining  risk  factors
which  contribute  to  the  development  of  a  disease.19 In  medi-
cal  history,  cohorts  play  an  important  role  in  documenting
associations,  like  in  the  Framingham  study,  or  the  conclusive
data  of  the  effectiveness  of  insulin  analogs  for  the  treatment
of  patients  with  type  1  or  2  diabetes.20 Additionally,  cohort
studies  help  determine  safety  proﬁles  of  medications.  For
example,  the  SCOUT  study  assessed  the  effectiveness  of
sibutramine  in  10,744  patients  with  obesity  and  high  cardio-
vascular  risk  for  a  period  of  6  years.  Compared  to  placebos,
the  sibutramine  group  showed  a  noticeable  increase  in  mor-
tality  rates  and  cardiovascular  events  despite  the  signiﬁcant
weight  loss.21 This  inﬂuenced  its  recall  by  the  FDA  in  2009.
In  contrast  with  experimental  studies,  studies  with-
out  intervention  represent  a  clearer,  uncontrolled  and
unadjusted  model  of  the  disease.  Nevertheless,  internal
validation  is  an  important  issue.  The  highest  difﬁculty  in
observational  studies  lies  in  interpretation,  since  there  are
some  factors  like  bias  in  selection,  confusion  factors  or  recall
bias  and  thus  the  results  may  lead  to  different  conclusions.
According  to  the  information  obtained,  it  is  possible
to  conclude  that  there  are  different  problems  in  research
within  primary  studies.  European  and  American  magazines
have  different  criteria  concerning  their  publication’s  guide-
lines;  in  other  words,  there  is  no  standard  in  the  level  of
evidence  regarding  article  revision.  Perhaps  a  major  implica-
tion  in  relation  to  the  impact  factor  lies  more  in  the  context
of  transnational  medicine.  That  is  to  say,  The  New  England
Journal  of  Medicine  published  mostly  randomized  clinical
trials,  studies  frequently  cited  and  with  a higher  impact  in
medical  practice.  Hence,  a  dichotomy  is  formed  between
the  management  of  concepts:  validity  versus  generalization.
Observational  studies  are  not  as  valid;  however  they  include
concepts  which  are  more  applicable  in  populations.  On  the
contrary,  experimental  studies  have  a  great  epistemological
value,  but  only  represent  the  set  of  the  population  being
studied.
Secondary  studies  represent  the  highest  level  of  evi-
dence.  They  offer  a  summary  of  the  investigation  question.
In  the  context  of  evidence-based  medicine,  both  validity  and
generalization  are  important.  The  ﬁndings  in  these  studies
have  a  greater  approximation  to  the  Bradford--Hill  criteria;
nevertheless,  the  limitation  in  secondary  studies  lies  in  the
presence  of  publication  bias.
One  of  the  strengths  of  this  study  was  the  analysis  of  a
representative  sample  of  the  publications  in  different  jour-
nals  in  the  yearly  period.  A  similar  trend  was  reported  in
a  study  conducted  in  2003,  but  with  different  objectives22
and  a  much  smaller  sample.  A  limitation  of  the  study  was
the  classiﬁcation  of  evidence  according  to  the  study  design,
without  evaluating  the  existence  of  discrepancies  in  the
methodology,  like  the  presence  of  bias  or  the  weight  of
confusion  factors.
In  conclusion,  the  tendency  of  publications  or  journals
with  a  high  impact  factor  is  oriented  to  a  greater  extent  to
the  publication  of  primary  and  observational  studies;  how-
ever,  European  journals  such  as  The  Lancet  and  BMJ  publish
a  good  amount  of  secondary  studies.  Future  studies  are
1141
ecessary  to  determine  not  only  the  validity,  but  also  the
mpact  of  an  article.  The  amount  of  quotations  correlated
ith  the  publication  of  studies  with  a  high  level  of  evidence.
onﬂict of interest
he  authors  have  no  conﬂicts  of  interest  to  declare.
unding
o  ﬁnancial  support  was  provided.
eferences
1. Guyatt G. Evidence-based medicine. JAMA. 1992;268:2420.
2. Frey JJ. Context is everything: how to decide if a journal article
is useful. WMJ. 2013;112:50--1.
3. Tilburt JC. Evidence-based medicine beyond the bedside: keep-
ing an eye on context. J Eval Clin Pract. 2008;14:721--5.
4. Saad A. The evidence-based paradox and the question of the
tree of knowledge. J Eval Clin Pract. 2008;14:650--2.
5. Ghosh AK. On the challenges of using evidence-based infor-
mation: the role of clinical uncertainty. J Lab Clin Med.
2004;144:60--4.
6. Wilson K. Evidence-based medicine. The good the bad
and the ugly. A clinician’s perspective. J Eval Clin Pract.
2010;16:398--400.
7. Hutchison KJ, Rogers WA. Challenging the epistemological foun-
dations of EBM: what kind of knowledge does clinical practice
require? J Eval Clin Pract. 2012;18:984--91.
8. Hjørland B. Evidence-based practice: an analysis based on
the philosophy of science. J Am Soc Inf Sci Technol.
2011;62:1301--10.
9. Zwolsman SE, van Dijk N, Te Pas E, Wieringa-de Waard M.
Barriers to the use of evidence-based medicine: knowledge
and skills, attitude, and external factors. Perspect Med Educ.
2013;2:4--13.
0. Aarssen LW, Lortie CJ, Budden AE, Koricheva J, Leimu R, Tre-
genza T. Does publication in top-tier journals affect reviewer
behavior? PLoS ONE. 2009;4:e6283.
1. Bala MM, Akl EA, Sun X, et al. Randomized trials published in
higher vs lower impact journals differ in design, conduct, and
analysis. J Clin Epidemiol. 2013;66:286--95.
2. Fernandes-Taylor S, Hyun JK, Reeder RN, Harris AH. Com-
mon  statistical and research design problems in manuscripts
submitted to high-impact medical journals. BMC Res Notes.
2011;4:304.
3. Tressoldi PE, Giofré D, Sella F, Cumming G. High impact = high
statistical standards? Not necessarily so. PLOS ONE.
2013;8:e56180.
4. Ferrill MJ, Brown DA, Kyle JA. Clinical versus statistical signif-
icance: interpreting P values and conﬁdence intervals related
to measures of association to guide decision making. J Pharm
Pract. 2010;23:344--51.study design. Air Med J. 1995;14:139--46.
7. Seshia SS, Young GB. The evidence-based medicine paradigm:
where are we 20 years later? Part 1. Can J Neurol Sci.
2013;40:465--74.
11
1
2
242  
8. Noordzij M, Dekker FW, Zoccali C, Jager KJ. Study designs in
clinical research. Nephron Clin Pract. 2009;113:c218--21.
9. Sorlie P, Wei GS. Population-based cohort studies: still relevant?
J Am Coll Cardiol. 2011;58:2010--3.
0. Ligthelm RJ, Borzì V, Gumprecht J, Kawamori R, Wenying Y,
Valensi P. Importance of observational studies in clinical prac-
tice. Clin Ther. 2007;29. Spec No: 1284--1292.
2H.E.  Tamez-Pérez  et  al.
1. James WPT, Caterson ID, Coutinho W,  et al. Effect of sibu-
tramine on cardiovascular outcomes in overweight and obese
subjects. N Engl J Med. 2010;363:905--17.2. Taback N, Krzyzanowska MK. A survey of abstracts of
high-impact clinical journals indicated most statistical meth-
ods presented are summary statistics. J Clin Epidemiol.
2008;61:277--81.
